NMPA Approval

Ustekinumab Injection (Intravenous Infusion)

Approval Number

国药准字SJ20200005

Registration Date

January 15, 2025

Previous Approval Numbers

S20200005

Drug Information

Generic Name

乌司奴单抗注射液(静脉输注)

Trade Name

喜达诺

Dosage Form

注射剂

Strength

130mg/26ml/瓶

Drug Type

生物制品

Registration Date

January 15, 2025

Expiry Date

January 14, 2030

Company Address

Turnhoutseweg 30, B-2340 Beerse, Belgium

Company NameCilag AG

Company Address

Hochstrasse 201, 8200 Schaffhausen, Switzerland

Empowering clinical research with data-driven insights and AI-powered tools.

乌司奴单抗注射液(静脉输注) - NMPA 批准文号 | MedPath